Jonathan C. Cohen

Molecular Biology · 2001–2021

A researcher in the Science corpus: 20 papers; trusts 2 researchers and is trusted by 11 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 66 citations into it
• Surgery — 57 citations into it; #254 of 1,106 by trust here, #85 by citations

Whom Jonathan C. Cohen trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Jay D. Horton

Who trusts Jonathan C. Cohen overall

1. Y. Kawano
2. J. Goldstein
3. B. E. Madsen
4. G. Kryukov
5. Steven A. McCarroll
6. Laura J. Dixon
7. Sekar Kathiresan
8. David Altshuler
9. D. Cohen
10. Michael S. Brown

Papers from Jonathan C. Cohen's perspective

Ordered by how strongly the researchers Jonathan C. Cohen trusts endorse each paper. Same corpus, a different order for every researcher.

1. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.
2. The prevalence and etiology of elevated aminotransferase levels in the United States (American Journal of Gastroenterology)
3. Molecular mediators of hepatic steatosis and liver injury. (Journal of Clinical Investigation)
4. Newly identified loci that influence lipid concentrations and risk of coronary artery disease (Nature Genetics)
5. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption (Nature Genetics)
6. Non-alcoholic fatty liver disease: the mist gradually clears. (Journal of Hepatology)
7. Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates (Proceedings of the National Academy of Sciences of the United States of America)
8. Binding of Proprotein Convertase Subtilisin/Kexin Type 9 to Epidermal Growth Factor-like Repeat A of Low Density Lipoprotein Receptor Decreases Receptor Recycling and Increases Degradation* (Journal of Biological Chemistry)
9. Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9. (Proceedings of the National Academy of Sciences of the United States of America)
10. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. (Science)

Their papers

• A Common Allele on Chromosome 9 Associated with Coronary Heart Disease (2007) — 1,486 citations
• An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing (2001) — 964 citations
• GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5 (2003) — 1,262 citations
• Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion (2002) — 785 citations
• A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride Hydrolysis (2009) — 620 citations
• Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote. (2006) — 659 citations
• Autosomal Recessive Hypercholesterolemia Caused by Mutations in a Putative LDL Receptor Adaptor Protein (2001) — 622 citations
• Binding of Proprotein Convertase Subtilisin/Kexin Type 9 to Epidermal Growth Factor-like Repeat A of Low Density Lipoprotein Receptor Decreases Receptor Recycling and Increases Degradation* (2007) — 782 citations
• Molecular basis of cholesterol efflux via ABCG subfamily transporters (2021) — 71 citations
• A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease (2018) — 665 citations
• Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease (2014) — 1,133 citations
• Human Fatty Liver Disease: Old Questions and New Insights (2011) — 2,072 citations
• Exome Sequencing, ANGPTL3 Mutations, and Familial Combined Hypolipidemia (2010) — 742 citations
• PCSK9: a convertase that coordinates LDL catabolism Published, JLR Papers in Press, November 19, 2008. (2009) — 613 citations
• Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease (2008) — 3,244 citations
• Molecular biology of PCSK9: its role in LDL metabolism. (2007) — 613 citations
• Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. (2006) — 3,129 citations
• Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity (2004) — 3,736 citations
• Multiple Rare Alleles Contribute to Low Plasma Levels of HDL Cholesterol (2004) — 1,127 citations
• Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. (2002) — 732 citations